Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
16 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
Four UNC nursing graduate students awarded American Cancer Society scholarships
by William Shawn Davis (wishda) published Jun 10, 2013 — filed under:
Four UNC School of Nursing students have been awarded American Cancer Society Graduate Scholarships in Cancer Nursing Practice. The recipients are Sean Gallagher, RN; April Lenker, RN; Melissa Matson, RN; and Lori Walker, RN.
Located in News
Ollila appointed James H. and Jesse E. Millis Distinguished Professor
by Dianne Shaw published Aug 26, 2013 — filed under:
David Ollila, MD, professor of surgery, has been appointed to the James H. and Jesse E. Millis Distinguished Professorship. The $1.5 million professorship was established by their son, William (Bill) Millis in honor of his parents, Jim and Jesse Millis of High Point, N.C.
Located in News
Murine study predicts cancer drug responsiveness in human tumors
by William Shawn Davis (wishda) published Jul 01, 2013 last modified Jul 03, 2013 05:13 PM — filed under:
It’s a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Located in News
UNC scientists identify possible KRAS downstream target for pancreatic cancer therapy
by Megan Fazekas-King (fazekask) published May 28, 2013 last modified Jun 13, 2013 02:22 PM — filed under:
While the mutated KRAS oncogene is associated with many cancers, it has not yet been successfully targeted by a therapeutic agent. Scientists are trying to find another way to target the gene by blocking signals from another protein downstream.
Located in News
UNC scientists identify possible KRAS downstream target for pancreatic cancer therapy
by William Shawn Davis (wishda) published May 28, 2013 last modified May 28, 2013 01:55 PM — filed under:
While the mutated KRAS oncogene is associated with many cancers, it has not yet been successfully targeted by a therapeutic agent. Scientists are trying to find another way to target the gene by blocking signals from another protein downstream.
Located in Old top news stories
New study shows on balance that prostate cancer prevention drug appears to provide benefit
by William Shawn Davis (wishda) published Aug 19, 2013 — filed under:
A team of researchers has published their analysis of survival rates among study participants in the 2003 Prostate Cancer Prevention Trial showing that the prostate drug finasteride does not decrease survival after a diagnosis of prostate cancer. Their 2003 publication found that while the drug finasteride significantly reduced the risk of prostate cancer, it was associated with an increased risk of high-grade disease and possibly decreased survival.
Located in News
NCI Provocative Questions grants awarded to three at UNC Lineberger
by William Shawn Davis (wishda) published Aug 20, 2013 last modified Aug 20, 2013 08:51 AM — filed under:
UNC Lineberger scientists Blossom Damania, PhD, Dirk Dittmer, PhD, and Liza Makowski, PhD, have been awarded two-year National Cancer Institute Provocative Questions grants.
Located in News
The value of randomized clinical trials in radiation oncology clinical practice
by William Shawn Davis (wishda) published May 29, 2013 last modified Jun 10, 2013 03:20 PM — filed under:
Cancer patients, physicians and insurers want to be sure that whatever therapy is recommended and provided to patients is based on evidence, preferably results from randomized clinical trials. But are there enough clinical trials data to provide this level of confidence?
Located in News
Pignone - Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added
by William Shawn Davis (wishda) published Jun 04, 2013 last modified Jun 06, 2013 09:07 AM — filed under:
While aspirin has been shown to be effective in preventing heart attacks in men, it also increases the risk of gastrointestinal bleeding and possibly stroke, even at low doses. As such, national guidelines suggest that aspirin be used for prevention only in men at higher risk for cardiovascular events, so that the benefits of aspirin are greater than its adverse effects.
Located in News
Murine study predicts cancer drug responsiveness in human tumors
by William Shawn Davis (wishda) published Jul 01, 2013 last modified Jul 01, 2013 10:31 AM — filed under:
It’s a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Located in Old top news stories